Top Suppliers:I want be here
Related CAS#:
357-70-0 104383-17-7
934415-11-9 1279031-09-2
41303-74-6 1953-04-4
1668-85-5 134332-50-6
142234-81-9 193146-85-9
879942-92-4 879943-07-4
879943-21-2 879943-69-8
879944-31-7 879944-70-4
879945-02-5 879945-09-2
879945-65-0 879946-63-1

357-70-0

357-70-0 structure
357-70-0 structure
  • Name: Galantamine
  • Chemical Name: galanthamine
  • CAS Number: 357-70-0
  • Molecular Formula: C17H21NO3
  • Molecular Weight: 287.353
  • Catalog: Biochemical Natural product
  • Create Date: 2018-07-01 20:29:12
  • Modify Date: 2025-08-20 12:52:05
  • Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM.
Name galanthamine
Synonyms MFCD00867189
3,4-Dihydrogalanthamine
Galantamine
Nivalin
6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-
Lycoremine
Galantamine Hydrobromide
(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol
Galanthamine
Description Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM.
Related Catalog
Target

IC50: 0.5 μM (AChE)[1]

In Vitro Galanthamine inhibits AChE and BChE with IC50 of 0.5 and 8.5 μM[1]. Galanthamine acts as a positive allosteric modulator (PAM) of human α4β2 AChRs expressed in permanently transfected HEK 293 cells. Galanthamine increases the response of (α4β2)2α5 AChRs to 1 μM ACh by up to 220% with very low concerntration(EC50=0.25 nM). Only small potentiation (20%) of either α4β2 or (α4β2)2β3 AChRs is detected using FLEXstation assays. Galanthamine at concentrations of 1 μM and above inhibits all three AChR subtypes[2].
In Vivo Acute administration of Galantamine (0.3-3 mg/kg, i.p.) increases IGF2 mRNA levels in the hippocampus, but not in the prefrontal cortex, in time- and dose-dependent manner. Galantamine (3 mg/kg, i.p.) causes a transient increase in fibroblast growth factor 2 mRNA levels and a decrease in brain-derived neurotrophic factor mRNA levels in the hippocampus, while it does not affect the mRNA levels of other neurotrophic/growth factors. The Galantamine-induced increase in the hippocampal IGF2 mRNA levels is blocked by Mecamylamine, a nonselective nicotinic acetylcholine (ACh) receptor (nAChR) antagonist, and Methyllycaconitine, a selective α7 nAChR antagonist, but not by Telenzepine, a preferential M1muscarinic ACh receptor antagonist. Moreover, the selective α7 nAChR agonist PHA-543613 increasea the IGF2 mRNA levels, while Donepezil, an acetylcholinesterase inhibitor, does not. Galantamine also increases hippocampal IGF2 protein, which is blocked by Methyllycaconitine[2].
Animal Admin Mice[2] Eight-week-old male ddY mice are housed in cages (24 cm×17 cm×12 cm) in each group of five to six animals under controlled environmental conditions (22±1°C; 12:12-h light-dark cycle, lights on at 0800 hours, food and water ad libitum) for 1 week before use in the experiments. 453 mice are used in total and in single use for each purpose. The following drugs are used: mecamylamine, methyllycaconitine, oxotremorine, and telenzepine, and Galantamine, Donepezil, and PHA-543613. All drugs are dissolved in saline (0.9 % solution of NaCl). Drugs are administered in a volume of 10 mL/kg intraperitoneally (i.p.) (Galantamine, Donepezil, Mecamylamine, Methyllycaconitine, Oxotremorine) or subcutaneously (s.c.) (PHA-543613, Telenzepine).
References

[1]. Melanie-Jayne R. Howes, et al. Acetylcholinesterase inhibitors of natural origin. International Journal of Research in Pharmaceutical and Biomedical Sciences 3(SI 1):67-86.

[2]. Kuryatov A, et al. Roles of accessory subunits in alpha4beta2(*) nicotinic receptors. Mol Pharmacol. 2008 Jul;74(1):132-43.

[3]. Kita Y, et al. Galantamine increases hippocampal insulin-like growth factor 2 expression via α7 nicotinic acetylcholine receptors in mice. Psychopharmacology (Berl). 2013 Feb;225(3):543-51.
Density 1.3±0.1 g/cm3
Boiling Point 439.3±45.0 °C at 760 mmHg
Melting Point 119-121ºC
Molecular Formula C17H21NO3
Molecular Weight 287.353
Flash Point 219.5±28.7 °C
Exact Mass 287.152130
PSA 41.93000
LogP 1.75
Vapour Pressure 0.0±1.1 mmHg at 25°C
Index of Refraction 1.636
Storage condition -20°C Freezer

CHEMICAL IDENTIFICATION

RTECS NUMBER :
LW5952100
CHEMICAL NAME :
Galanthamine
CAS REGISTRY NUMBER :
357-70-0
BEILSTEIN REFERENCE NO. :
0093736
LAST UPDATED :
199706
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C17-H21-N-O3
MOLECULAR WEIGHT :
287.39

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
22900 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #5177082
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 37,689,1994
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
14 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4550113
Hazard Codes Xi
HS Code 2942000000
HS Code 2942000000
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Chemsrc provides CAS#:357-70-0 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 357-70-0 | Chemsrc address: https://www.chemsrc.com/en/baike/894780.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved